Skip to main content
. 2010 May 25;8(5):1716–1730. doi: 10.3390/md8051716

Table 2.

Summary of the main pharmacokinetic parameters for the test and reference products directly estimated from the plasma concentration-time data.

Tmax Cmax T0.5 AUC0-t AUC0-∞

Vol. No. T R T R T R T R T R
1 5.00 4.00 7.96 2.62 18.74 151.10 91.74 43.81 123.65 372.97
2 5.50 10.00 7.08 3.16 20.64 44.15 81.53 52.71 122.63 119.59
3 3.00 6.50 11.93 4.75 16.73 23.84 107.45 70.89 132.07 115.95
4 4.00 5.00 9.28 3.25 27.42 50.73 121.67 63.73 214.62 213.04
5 5.00 6.00 8.98 8.24 23.91 27.09 108.18 112.73 179.23 212.39
6 4.00 5.00 9.32 3.93 22.61 31.77 97.77 63.60 147.04 125.93
7 5.00 8.00 9.11 3.27 27.89 93.25 103.72 57.19 185.00 332.97
8 4.00 6.50 9.75 5.19 26.45 59.22 124.67 71.48 213.97 276.53

G_Mean 4.37 6.14 9.08 4.03 22.71 49.88 103.70 64.67 160.86 201.46
STDEV 0.82 1.90 1.41 1.81 4.13 42.98 14.44 20.66 38.50 99.44
SEM 0.29 0.67 0.50 0.64 1.46 15.20 5.11 7.30 13.61 35.16
% CV 18.50 29.87 15.33 42.09 17.91 71.46 13.81 30.82 23.36 44.96